The current institutional shareholding score of INmune Bio Inc is 3.00, ranking 193 out of 389 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 18.84%, representing a quarter-over-quarter increase of 8.44%. The largest institutional shareholder is ETHSX, holding a total of 22.09K shares, representing 0.10% of shares outstanding, with 0.00% increase in holdings.